Dunson et al v. AstraZeneca Pharmaceuticals et al
Stephen Dunson and Shaun Dunson |
JOHN DOE #1-#10, ABC CORPORATION'S 1-10, ASTRAZENECA LP, Astrazeneca Pharmaceuticals, JANE DOE #1-10, PFIZER INC, THE PROCTER & GAMBLE COMPANY, ASTRAZENECA PHARMACEUTICALS LP, GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC and GLAXOSMITHKLINE CONSUMER HEALTH, INC |
PROTON-PUMP INHIBITOR PRODUCTS LIABILITY LITIGATION (No. II) |
2:2020cv00789 |
January 23, 2020 |
US District Court for the District of New Jersey |
Claire C Cecchi |
Mark Falk |
Leda D Wettre |
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
28 U.S.C. § 1332 Diversity-Product Liability |
Plaintiff |
Docket Report
This docket was last retrieved on February 3, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 14 ORDER that GSK Defendants shall be DISMISSED without prejudice (filed in Master - MDL ORDER REGARDING CMO 66 re GSK Defendants [DE#724]). GLAXOSMITHKLINE CONSUMER HEALTH, INC and GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC terminated. Signed by Judge Claire C. Cecchi on 12/22/2022. (jl, ) |
Filing 13 ORDER that Abbott shall be DISMISSED without prejudice (filed in Master - DL ORDER REGARDING CMO 65 re AZ Defendants [DE#723]). ASTRAZENECA LP and ASTRAZENECA PHARMACEUTICALS LP terminated. Signed by Judge Claire C. Cecchi on 12/22/2022. (jl, ) |
Filing 12 ORDER that Pfizer shall be DISMISSED without prejudice (filed in Master - MDL ORDER REGARDING CMO 60 re Pfizer Defendants [DE#709]). PFIZER INC. terminated. Signed by Judge Claire C. Cecchi on 12/22/2022. (jl, ) |
Filing 11 RESPONSE TO ORDER TO SHOW CAUSE by GLAXOSMITHKLINE CONSUMER HEALTH, INC, GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC. (MCCONNELL, STEPHEN) |
Filing 10 RESPONSE TO ORDER TO SHOW CAUSE by ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP. (HINDY, GREGORY) |
Case reassigned to Magistrate Judge Leda D. Wettre. Chief Mag. Judge Mark Falk no longer assigned to the case. (jr) |
Filing 9 ORDER TO SHOW CAUSE - Plaintiffs enumerated on the attached Exhibit A are hereby ordered to show cause within thirty (30) days of the date of this Order to (1) establish that service was effected on the identified GSK Defendants3 as required by Rule 4(m) by filing proof of service, (2) voluntarily dismiss the identified GSK Defendants, or (3) show cause why the identified GSK Defendants should not be dismissed. (Special Master Order). Signed by Ellen Reisman, Special Master on 12/2/2021.(jl, ) |
Filing 8 ORDER TO SHOW CAUSE - Plaintiffs enumerated on the attached Exhibit A are hereby ordered to show cause within thirty (30) days of the date of this Order to (1) establish that service was effected on the identified AZ Defendants as required by Rule 4(m) by filing proof of service, (2) voluntarily dismiss the identified AZ Defendants, or (3) show cause why the identified AZ Defendants should not be dismissed. (Special Master Order). Signed by Ellen Reisman, Special Master on 12/2/2021.(jl, ) |
Filing 7 ORDER TO SHOW CAUSE - Plaintiffs enumerated on the attached Exhibit A are hereby ordered to show cause within thirty (30) days as follows (1) establish that service was effected on Pfizer as required by Rule 4(m) by filing proof of service, (2) voluntarily dismiss Pfizer, or (3) show cause why Pfizer should not be dismissed. (Special Master Order). Signed by Ellen Reisman, Special Master on 11/19/2021. (jl, ) |
Filing 6 STIPULATION AND ORDER ADDING DEFENDANTS GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC and GLAXOSMITHKLINE CONSUMER HEALTH, INC. Signed by Judge Claire C. Cecchi on 12/31/2020. (krg, ) |
Filing 5 Clerk's Notice to Counsel. (gh, ) |
Filing 4 Certified Copy of Transfer Order and docket received, Case transferred in from District of Missouri Western; Case Number 4:20-cv-00008. Original file certified copy of transfer order and docket sheet received. |
Filing 3 MDL CONDITIONAL TRANSFER ORDER, CTO-26, from John W Nichols, Clerk of the Panel, transferring case to District of New Jersey to be included in MDL No. 2789. Signed on 1/23/2020. Case electronically transferred. (Attachments: #1 Letter) (Ellis, Lindsey) |
Judge Claire C. Cecchi and Chief Mag. Judge Mark Falk added. (gh, ) |
Member Case Transferred in on 1/23/20 from the Western District of Missouri 4:20-00008 for MDL 2789 - PROTON-PUMP INHIBITOR PRODUCTS LIABILITY LITIGATION (No. II) (gh, ) |
SUMMONS ISSUED as to AstraZeneca Pharmaceuticals, AstraZeneca Pharmaceuticals, LP, Astrazeneca, LP, Pfizer, Inc. (Melvin, Greg) |
Filing 2 NOTICE OF INCLUSION FOR MEDIATION AND ASSESSMENT PROGRAM (MAP). REVIEW NOTICE AND MAP GENERAL ORDER CAREFULLY FOR DEADLINES AND REQUIREMENTS.Notice of MAP assignment to Program Director. (Attachments: #1 MAP General Order)(Woods, Gloria) |
Filing 1 COMPLAINT against ABC Corporations 1-10, AstraZeneca Pharmaceuticals, AstraZeneca Pharmaceuticals, LP, Astrazeneca, LP, Jane Doe 1-10, John Doe 1-10, Pfizer, Inc., Procter & Gamble Company, The filed by Gerald Gray, II on behalf of Shaun Dunson, Stephen Dunson. Filing fee $400, receipt number BMOWDC-6652484. Service due by 4/2/2020 unless otherwise directed by the court. (Attachments: #1 Civil Cover Sheet)(Gray, Gerald) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.